FindTrial
Sign In

Comparison of Radiofrequency Ablation and Steroid Injection for Chronic Low Back Pain Due to Facet Joint Disease

Randomized Controlled Trial on Comparison of Facet Joint Radiofrequency Denervation vs Facet Joint Steroid Injection in Chronic Low Back Pain of Facet Origin - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082540
Enrollment
100
Registered
2025-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: M478- Other spondylosis

Interventions

Intervention1: Facet joint radiofrequency denervation : Fluoroscopy-guided Radiofrequency denervation will be performed using a cooled tip thermal radiofrequency technique, with a target temperature o

Sponsors

AIIMS research section
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Chronic low back pain of at least 3 months duration 2. Clinical features suggestive of facet joint origin, including paraspinal tenderness, pain worsened by extension and rotation, and absence of radicular symptoms 3. Failure of conservative therapy, including medications (e.g., NSAIDs, weak opioids) and physical therapy, for at least 6 weeks

Exclusion criteria

Exclusion criteria: - Presence of radicular pain or neurological deficits suggestive of nerve root involvement - Previous lumbar spine surgery - Significant spinal pathology, such as fracture, tumor, infection, or instability - Coagulopathy or systemic infection - Allergy to study medications (local anesthetics, steroids) - Pregnancy or lactation - Cognitive impairment or psychiatric illness that may interfere with assessment of outcomes

Design outcomes

Primary

MeasureTime frame
Low Back Pain intensity as measured by the NRS (0-10)Timepoint: At baseline, 1 month, 3 months, 6 months and 1 year post treatment—

Secondary

MeasureTime frame
Pain intensity measured by the VAS (0-100 mm) Functional status assessed by the Modified ODI at baseline and all follow-up visits Health-related quality of life measured by the SF-12 at baseline and all follow-up visits Time to first repeat procedure and total number of repeat procedures during the 1-year follow-up period Adverse events, including procedural complications, new or worsening pain, and neurological deficits, assessed at each visit Timepoint: baseline, 1 month, 3 months, 6 months, and 1 year post-treatment—

Countries

India

Contacts

Public ContactStanzin Spalkit

AIIMS New Delhi

stanzn156@gmail.com8860321558

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026